 | • レポートコード：QYR2104Z0795 • 出版社/出版日：QYResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、92ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療 |
| Single User | ￥546,000 (USD3,900) | ▷ お問い合わせ |
| Multi User/Five User | ￥819,000 (USD5,850) | ▷ お問い合わせ |
| Enterprise License（同一法人内共有可） | ￥1,092,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の本調査資料では、生物学的治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（ワクチン、血液製剤、アレルギー性抽出物、ヒト細胞・組織、遺伝子治療、タンパク質、細胞治療、異種移植製品）、用途別市場規模（関節リウマチ、貧血、がん、糖尿病、その他）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・生物学的治療の市場動向 ・企業の競争状況、市場シェア ・生物学的治療の種類別市場規模（ワクチン、血液製剤、アレルギー性抽出物、ヒト細胞・組織、遺伝子治療、タンパク質、細胞治療、異種移植製品） ・生物学的治療の用途別市場規模（関節リウマチ、貧血、がん、糖尿病、その他） ・生物学的治療の北米市場規模2016-2027（アメリカ、カナダ） ・生物学的治療のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・生物学的治療のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・生物学的治療の中南米市場規模2016-2027（メキシコ、ブラジル） ・生物学的治療の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Pfizer、Novartis Global、AstraZeneca、Merck、GlaxoSmithKline、Aurobindo Pharma） ・結論 |
Biologic therapeutics drugs are genetically engineered proteins derived from human genetic material. They contain sugars, proteins, nucleic acids, or complex combinations of these substances, or may be living entities such as cells and tissues. In addition, biologics drugs are derived from natural sources such as animals, humans, and microorganisms that are further utilized to make therapeutic products such as vaccines, blood components, and recombinant therapeutic proteins.
First and foremost, increasing reimbursement for biologics is predicted to positively influence the biologic therapeutics market in the upcoming years. Medical insurance companies and state-run insurance schemes are increasingly accepting claims against biologic therapeutics. Biologic therapeutics are gaining popularity due the efficacy of biologic therapeutic drugs and fewer side effects than chemical-based drugs. This is because biologic drugs are obtained from natural sources such as plants, or even living components such as cells and tissues of animals, microorganisms, or humans. These fragments are further treated to make therapeutic products such as blood components, vaccines, and recombinant therapeutic proteins.
Market Analysis and Insights: Global Biologic Therapeutics Market
The global Biologic Therapeutics market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Biologic Therapeutics market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Biologic Therapeutics market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Biologic Therapeutics market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Biologic Therapeutics market.
Global Biologic Therapeutics Scope and Market Size
Biologic Therapeutics market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Biologic Therapeutics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
Vaccines
Blood Products
Allergenic Extracts
Human Cells and Tissues
Gene Therapies
Protein
Cellular Therapies
Xenotransplantation Products
Segment by Application
Rheumatoid Arthritis
Anemia
Cancer
Diabetes
Others
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
Pfizer
Novartis Global
AstraZeneca
Merck
GlaxoSmithKline
Aurobindo Pharma
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Biologic Therapeutics Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Vaccines
1.2.3 Blood Products
1.2.4 Allergenic Extracts
1.2.5 Human Cells and Tissues
1.2.6 Gene Therapies
1.2.7 Protein
1.2.8 Cellular Therapies
1.2.9 Xenotransplantation Products
1.3 Market by Application
1.3.1 Global Biologic Therapeutics Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Rheumatoid Arthritis
1.3.3 Anemia
1.3.4 Cancer
1.3.5 Diabetes
1.3.6 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Biologic Therapeutics Market Perspective (2016-2027)
2.2 Biologic Therapeutics Growth Trends by Regions
2.2.1 Biologic Therapeutics Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Biologic Therapeutics Historic Market Share by Regions (2016-2021)
2.2.3 Biologic Therapeutics Forecasted Market Size by Regions (2022-2027)
2.3 Biologic Therapeutics Industry Dynamic
2.3.1 Biologic Therapeutics Market Trends
2.3.2 Biologic Therapeutics Market Drivers
2.3.3 Biologic Therapeutics Market Challenges
2.3.4 Biologic Therapeutics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Biologic Therapeutics Players by Revenue
3.1.1 Global Top Biologic Therapeutics Players by Revenue (2016-2021)
3.1.2 Global Biologic Therapeutics Revenue Market Share by Players (2016-2021)
3.2 Global Biologic Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Biologic Therapeutics Revenue
3.4 Global Biologic Therapeutics Market Concentration Ratio
3.4.1 Global Biologic Therapeutics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Biologic Therapeutics Revenue in 2020
3.5 Biologic Therapeutics Key Players Head office and Area Served
3.6 Key Players Biologic Therapeutics Product Solution and Service
3.7 Date of Enter into Biologic Therapeutics Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Biologic Therapeutics Breakdown Data by Type
4.1 Global Biologic Therapeutics Historic Market Size by Type (2016-2021)
4.2 Global Biologic Therapeutics Forecasted Market Size by Type (2022-2027)
5 Biologic Therapeutics Breakdown Data by Application
5.1 Global Biologic Therapeutics Historic Market Size by Application (2016-2021)
5.2 Global Biologic Therapeutics Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Biologic Therapeutics Market Size (2016-2027)
6.2 North America Biologic Therapeutics Market Size by Type
6.2.1 North America Biologic Therapeutics Market Size by Type (2016-2021)
6.2.2 North America Biologic Therapeutics Market Size by Type (2022-2027)
6.2.3 North America Biologic Therapeutics Market Size by Type (2016-2027)
6.3 North America Biologic Therapeutics Market Size by Application
6.3.1 North America Biologic Therapeutics Market Size by Application (2016-2021)
6.3.2 North America Biologic Therapeutics Market Size by Application (2022-2027)
6.3.3 North America Biologic Therapeutics Market Size by Application (2016-2027)
6.4 North America Biologic Therapeutics Market Size by Country
6.4.1 North America Biologic Therapeutics Market Size by Country (2016-2021)
6.4.2 North America Biologic Therapeutics Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada
7 Europe
7.1 Europe Biologic Therapeutics Market Size (2016-2027)
7.2 Europe Biologic Therapeutics Market Size by Type
7.2.1 Europe Biologic Therapeutics Market Size by Type (2016-2021)
7.2.2 Europe Biologic Therapeutics Market Size by Type (2022-2027)
7.2.3 Europe Biologic Therapeutics Market Size by Type (2016-2027)
7.3 Europe Biologic Therapeutics Market Size by Application
7.3.1 Europe Biologic Therapeutics Market Size by Application (2016-2021)
7.3.2 Europe Biologic Therapeutics Market Size by Application (2022-2027)
7.3.3 Europe Biologic Therapeutics Market Size by Application (2016-2027)
7.4 Europe Biologic Therapeutics Market Size by Country
7.4.1 Europe Biologic Therapeutics Market Size by Country (2016-2021)
7.4.2 Europe Biologic Therapeutics Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Biologic Therapeutics Market Size (2016-2027)
8.2 Asia-Pacific Biologic Therapeutics Market Size by Type
8.2.1 Asia-Pacific Biologic Therapeutics Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Biologic Therapeutics Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Biologic Therapeutics Market Size by Type (2016-2027)
8.3 Asia-Pacific Biologic Therapeutics Market Size by Application
8.3.1 Asia-Pacific Biologic Therapeutics Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Biologic Therapeutics Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Biologic Therapeutics Market Size by Application (2016-2027)
8.4 Asia-Pacific Biologic Therapeutics Market Size by Region
8.4.1 Asia-Pacific Biologic Therapeutics Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Biologic Therapeutics Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Biologic Therapeutics Market Size (2016-2027)
9.2 Latin America Biologic Therapeutics Market Size by Type
9.2.1 Latin America Biologic Therapeutics Market Size by Type (2016-2021)
9.2.2 Latin America Biologic Therapeutics Market Size by Type (2022-2027)
9.2.3 Latin America Biologic Therapeutics Market Size by Type (2016-2027)
9.3 Latin America Biologic Therapeutics Market Size by Application
9.3.1 Latin America Biologic Therapeutics Market Size by Application (2016-2021)
9.3.2 Latin America Biologic Therapeutics Market Size by Application (2022-2027)
9.3.3 Latin America Biologic Therapeutics Market Size by Application (2016-2027)
9.4 Latin America Biologic Therapeutics Market Size by Country
9.4.1 Latin America Biologic Therapeutics Market Size by Country (2016-2021)
9.4.2 Latin America Biologic Therapeutics Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Biologic Therapeutics Market Size (2016-2027)
10.2 Middle East & Africa Biologic Therapeutics Market Size by Type
10.2.1 Middle East & Africa Biologic Therapeutics Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Biologic Therapeutics Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Biologic Therapeutics Market Size by Type (2016-2027)
10.3 Middle East & Africa Biologic Therapeutics Market Size by Application
10.3.1 Middle East & Africa Biologic Therapeutics Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Biologic Therapeutics Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Biologic Therapeutics Market Size by Application (2016-2027)
10.4 Middle East & Africa Biologic Therapeutics Market Size by Country
10.4.1 Middle East & Africa Biologic Therapeutics Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Biologic Therapeutics Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Pfizer
11.1.1 Pfizer Company Details
11.1.2 Pfizer Business Overview
11.1.3 Pfizer Biologic Therapeutics Introduction
11.1.4 Pfizer Revenue in Biologic Therapeutics Business (2016-2021)
11.1.5 Pfizer Recent Development
11.2 Novartis Global
11.2.1 Novartis Global Company Details
11.2.2 Novartis Global Business Overview
11.2.3 Novartis Global Biologic Therapeutics Introduction
11.2.4 Novartis Global Revenue in Biologic Therapeutics Business (2016-2021)
11.2.5 Novartis Global Recent Development
11.3 AstraZeneca
11.3.1 AstraZeneca Company Details
11.3.2 AstraZeneca Business Overview
11.3.3 AstraZeneca Biologic Therapeutics Introduction
11.3.4 AstraZeneca Revenue in Biologic Therapeutics Business (2016-2021)
11.3.5 AstraZeneca Recent Development
11.4 Merck
11.4.1 Merck Company Details
11.4.2 Merck Business Overview
11.4.3 Merck Biologic Therapeutics Introduction
11.4.4 Merck Revenue in Biologic Therapeutics Business (2016-2021)
11.4.5 Merck Recent Development
11.5 GlaxoSmithKline
11.5.1 GlaxoSmithKline Company Details
11.5.2 GlaxoSmithKline Business Overview
11.5.3 GlaxoSmithKline Biologic Therapeutics Introduction
11.5.4 GlaxoSmithKline Revenue in Biologic Therapeutics Business (2016-2021)
11.5.5 GlaxoSmithKline Recent Development
11.6 Aurobindo Pharma
11.6.1 Aurobindo Pharma Company Details
11.6.2 Aurobindo Pharma Business Overview
11.6.3 Aurobindo Pharma Biologic Therapeutics Introduction
11.6.4 Aurobindo Pharma Revenue in Biologic Therapeutics Business (2016-2021)
11.6.5 Aurobindo Pharma Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global Biologic Therapeutics Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Vaccines
Table 3. Key Players of Blood Products
Table 4. Key Players of Allergenic Extracts
Table 5. Key Players of Human Cells and Tissues
Table 6. Key Players of Gene Therapies
Table 7. Key Players of Protein
Table 8. Key Players of Cellular Therapies
Table 9. Key Players of Xenotransplantation Products
Table 10. Global Biologic Therapeutics Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 11. Global Biologic Therapeutics Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 12. Global Biologic Therapeutics Market Size by Regions (2016-2021) & (US$ Million)
Table 13. Global Biologic Therapeutics Market Share by Regions (2016-2021)
Table 14. Global Biologic Therapeutics Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 15. Global Biologic Therapeutics Market Share by Regions (2022-2027)
Table 16. Biologic Therapeutics Market Trends
Table 17. Biologic Therapeutics Market Drivers
Table 18. Biologic Therapeutics Market Challenges
Table 19. Biologic Therapeutics Market Restraints
Table 20. Global Biologic Therapeutics Revenue by Players (2016-2021) & (US$ Million)
Table 21. Global Biologic Therapeutics Market Share by Players (2016-2021)
Table 22. Global Top Biologic Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Biologic Therapeutics as of 2020)
Table 23. Ranking of Global Top Biologic Therapeutics Companies by Revenue (US$ Million) in 2020
Table 24. Global 5 Largest Players Market Share by Biologic Therapeutics Revenue (CR5 and HHI) & (2016-2021)
Table 25. Key Players Headquarters and Area Served
Table 26. Key Players Biologic Therapeutics Product Solution and Service
Table 27. Date of Enter into Biologic Therapeutics Market
Table 28. Mergers & Acquisitions, Expansion Plans
Table 29. Global Biologic Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 30. Global Biologic Therapeutics Revenue Market Share by Type (2016-2021)
Table 31. Global Biologic Therapeutics Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 32. Global Biologic Therapeutics Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 33. Global Biologic Therapeutics Market Size Share by Application (2016-2021) & (US$ Million)
Table 34. Global Biologic Therapeutics Revenue Market Share by Application (2016-2021)
Table 35. Global Biologic Therapeutics Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 36. Global Biologic Therapeutics Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 37. North America Biologic Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 38. North America Biologic Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 39. North America Biologic Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 40. North America Biologic Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 41. North America Biologic Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 42. North America Biologic Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 43. Europe Biologic Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 44. Europe Biologic Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 45. Europe Biologic Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 46. Europe Biologic Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 47. Europe Biologic Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 48. Europe Biologic Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 49. Asia-Pacific Biologic Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 50. Asia-Pacific Biologic Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 51. Asia-Pacific Biologic Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 52. Asia-Pacific Biologic Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 53. Asia-Pacific Biologic Therapeutics Market Size by Region (2016-2021) & (US$ Million)
Table 54. Asia-Pacific Biologic Therapeutics Market Size by Region (2022-2027) & (US$ Million)
Table 55. Latin America Biologic Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 56. Latin America Biologic Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 57. Latin America Biologic Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 58. Latin America Biologic Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 59. Latin America Biologic Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 60. Latin America Biologic Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 61. Middle East & Africa Biologic Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 62. Middle East & Africa Biologic Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 63. Middle East & Africa Biologic Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 64. Middle East & Africa Biologic Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 65. Middle East & Africa Biologic Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 66. Middle East & Africa Biologic Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 67. Pfizer Company Details
Table 68. Pfizer Business Overview
Table 69. Pfizer Biologic Therapeutics Product
Table 70. Pfizer Revenue in Biologic Therapeutics Business (2016-2021) & (US$ Million)
Table 71. Pfizer Recent Development
Table 72. Novartis Global Company Details
Table 73. Novartis Global Business Overview
Table 74. Novartis Global Biologic Therapeutics Product
Table 75. Novartis Global Revenue in Biologic Therapeutics Business (2016-2021) & (US$ Million)
Table 76. Novartis Global Recent Development
Table 77. AstraZeneca Company Details
Table 78. AstraZeneca Business Overview
Table 79. AstraZeneca Biologic Therapeutics Product
Table 80. AstraZeneca Revenue in Biologic Therapeutics Business (2016-2021) & (US$ Million)
Table 81. AstraZeneca Recent Development
Table 82. Merck Company Details
Table 83. Merck Business Overview
Table 84. Merck Biologic Therapeutics Product
Table 85. Merck Revenue in Biologic Therapeutics Business (2016-2021) & (US$ Million)
Table 86. Merck Recent Development
Table 87. GlaxoSmithKline Company Details
Table 88. GlaxoSmithKline Business Overview
Table 89. GlaxoSmithKline Biologic Therapeutics Product
Table 90. GlaxoSmithKline Revenue in Biologic Therapeutics Business (2016-2021) & (US$ Million)
Table 91. GlaxoSmithKline Recent Development
Table 92. Aurobindo Pharma Company Details
Table 93. Aurobindo Pharma Business Overview
Table 94. Aurobindo Pharma Biologic Therapeutics Product
Table 95. Aurobindo Pharma Revenue in Biologic Therapeutics Business (2016-2021) & (US$ Million)
Table 96. Aurobindo Pharma Recent Development
Table 97. Research Programs/Design for This Report
Table 98. Key Data Information from Secondary Sources
Table 99. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Biologic Therapeutics Market Share by Type: 2020 VS 2027
Figure 2. Vaccines Features
Figure 3. Blood Products Features
Figure 4. Allergenic Extracts Features
Figure 5. Human Cells and Tissues Features
Figure 6. Gene Therapies Features
Figure 7. Protein Features
Figure 8. Cellular Therapies Features
Figure 9. Xenotransplantation Products Features
Figure 10. Global Biologic Therapeutics Market Share by Application: 2020 VS 2027
Figure 11. Rheumatoid Arthritis Case Studies
Figure 12. Anemia Case Studies
Figure 13. Cancer Case Studies
Figure 14. Diabetes Case Studies
Figure 15. Others Case Studies
Figure 16. Biologic Therapeutics Report Years Considered
Figure 17. Global Biologic Therapeutics Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 18. Global Biologic Therapeutics Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 19. Global Biologic Therapeutics Market Share by Regions: 2020 VS 2027
Figure 20. Global Biologic Therapeutics Market Share by Regions (2022-2027)
Figure 21. Global Biologic Therapeutics Market Share by Players in 2020
Figure 22. Global Top Biologic Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Biologic Therapeutics as of 2020
Figure 23. The Top 10 and 5 Players Market Share by Biologic Therapeutics Revenue in 2020
Figure 24. Global Biologic Therapeutics Revenue Market Share by Type (2016-2021)
Figure 25. Global Biologic Therapeutics Revenue Market Share by Type (2022-2027)
Figure 26. North America Biologic Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. North America Biologic Therapeutics Market Share by Type (2016-2027)
Figure 28. North America Biologic Therapeutics Market Share by Application (2016-2027)
Figure 29. North America Biologic Therapeutics Market Share by Country (2016-2027)
Figure 30. United States Biologic Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. Canada Biologic Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Europe Biologic Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Europe Biologic Therapeutics Market Share by Type (2016-2027)
Figure 34. Europe Biologic Therapeutics Market Share by Application (2016-2027)
Figure 35. Europe Biologic Therapeutics Market Share by Country (2016-2027)
Figure 36. Germany Biologic Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. France Biologic Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. U.K. Biologic Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Italy Biologic Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Russia Biologic Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Nordic Biologic Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Asia-Pacific Biologic Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Asia-Pacific Biologic Therapeutics Market Share by Type (2016-2027)
Figure 44. Asia-Pacific Biologic Therapeutics Market Share by Application (2016-2027)
Figure 45. Asia-Pacific Biologic Therapeutics Market Share by Region (2016-2027)
Figure 46. China Biologic Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Japan Biologic Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. South Korea Biologic Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Southeast Asia Biologic Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. India Biologic Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Australia Biologic Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Latin America Biologic Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Latin America Biologic Therapeutics Market Share by Type (2016-2027)
Figure 54. Latin America Biologic Therapeutics Market Share by Application (2016-2027)
Figure 55. Latin America Biologic Therapeutics Market Share by Country (2016-2027)
Figure 56. Mexico Biologic Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Brazil Biologic Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. Middle East & Africa Biologic Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. Middle East & Africa Biologic Therapeutics Market Share by Type (2016-2027)
Figure 60. Middle East & Africa Biologic Therapeutics Market Share by Application (2016-2027)
Figure 61. Middle East & Africa Biologic Therapeutics Market Share by Country (2016-2027)
Figure 62. Turkey Biologic Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 63. Saudi Arabia Biologic Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 64. UAE Biologic Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 65. Pfizer Revenue Growth Rate in Biologic Therapeutics Business (2016-2021)
Figure 66. Novartis Global Revenue Growth Rate in Biologic Therapeutics Business (2016-2021)
Figure 67. AstraZeneca Revenue Growth Rate in Biologic Therapeutics Business (2016-2021)
Figure 68. Merck Revenue Growth Rate in Biologic Therapeutics Business (2016-2021)
Figure 69. GlaxoSmithKline Revenue Growth Rate in Biologic Therapeutics Business (2016-2021)
Figure 70. Aurobindo Pharma Revenue Growth Rate in Biologic Therapeutics Business (2016-2021)
Figure 71. Bottom-up and Top-down Approaches for This Report
Figure 72. Data Triangulation
Figure 73. Key Executives Interviewed
世界の自家幹細胞ベース治療法市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Autologous Stem Cell Based Therapies Market The global Autologous Stem Cell Based Therapies market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026. With industry-standard accuracy in analysis and h…- 世界のプラズマ治療薬市場規模・現状・予測（2021年-2027年） Plasma, pale yellow in color, is the component of the blood. To calculate the market size, the report considers revenue generated from the sales of branded therapies derived from the various fractions of plasma such as albumin, immunoglobulins, coagulation factors, hyperimmune globulins, and A1PI. M…
- 世界の関節リウマチ治療市場規模・現状・予測（2021年-2027年） Rheumatoid arthritis is a long-term autoimmune disorder that primarily affects joints. The rheumatoid arthritis treatment market is expected to grow over the forecast period owing to the high incidence rate of rheumatoid arthritis among people. Market Analysis and Insights: Global Rheumatoid Arthrit…
- 世界の関節リウマチ治療市場規模・現状・予測（2021年-2027年） Rheumatoid arthritis is a long-term autoimmune disorder that primarily affects joints. The rheumatoid arthritis treatment market is expected to grow over the forecast period owing to the high incidence rate of rheumatoid arthritis among people. Market Analysis and Insights: Global Rheumatoid Arthrit…
- 世界の変形性関節症用再生療法市場規模・現状・予測（2021年-2027年） Osteoarthritis is a type of joint disease that results from breakdown of joint cartilage and underlying bone. The increasing incidence of osteoarthritis is expected to drive the regenerative therapies for osteoarthritis market. Market Analysis and Insights: Global Regenerative Therapies for Osteoart…